IRIS
TONINI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 24.573
NA - Nord America 14.977
EU - Europa 4.946
SA - Sud America 2.083
AF - Africa 237
Continente sconosciuto - Info sul continente non disponibili 164
OC - Oceania 66
AN - Antartide 2
Totale 47.048
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 16.394
US - Stati Uniti d'America 14.344
CN - Cina 3.353
HK - Hong Kong 2.545
IT - Italia 2.414
BR - Brasile 1.367
GB - Regno Unito 794
VN - Vietnam 775
FR - Francia 605
BD - Bangladesh 382
DE - Germania 333
CA - Canada 285
IN - India 280
AR - Argentina 203
MX - Messico 172
CO - Colombia 166
EC - Ecuador 142
ID - Indonesia 142
NL - Olanda 134
TR - Turchia 95
ZA - Sudafrica 91
FI - Finlandia 84
VE - Venezuela 72
ES - Italia 69
JP - Giappone 67
SA - Arabia Saudita 62
RU - Federazione Russa 59
UA - Ucraina 59
AU - Australia 58
PH - Filippine 53
MY - Malesia 51
PL - Polonia 51
IQ - Iraq 50
EE - Estonia 40
PK - Pakistan 40
CR - Costa Rica 39
CZ - Repubblica Ceca 39
CL - Cile 38
PY - Paraguay 35
PE - Perù 33
SE - Svezia 33
TH - Thailandia 33
MD - Moldavia 29
JM - Giamaica 28
UZ - Uzbekistan 28
CH - Svizzera 22
NP - Nepal 22
MA - Marocco 21
BG - Bulgaria 19
LT - Lituania 19
BE - Belgio 18
KR - Corea 17
AT - Austria 16
DZ - Algeria 16
JO - Giordania 16
TN - Tunisia 16
TT - Trinidad e Tobago 16
HN - Honduras 15
IL - Israele 15
RO - Romania 15
EG - Egitto 14
TW - Taiwan 14
UY - Uruguay 14
AE - Emirati Arabi Uniti 13
BH - Bahrain 13
KE - Kenya 13
KZ - Kazakistan 13
DO - Repubblica Dominicana 12
KW - Kuwait 12
NI - Nicaragua 12
GT - Guatemala 11
AZ - Azerbaigian 10
ET - Etiopia 10
AL - Albania 9
BA - Bosnia-Erzegovina 9
BO - Bolivia 9
HU - Ungheria 9
IE - Irlanda 9
PT - Portogallo 9
SI - Slovenia 9
LB - Libano 8
OM - Oman 8
PS - Palestinian Territory 8
IR - Iran 7
QA - Qatar 7
RS - Serbia 7
SV - El Salvador 7
XK - ???statistics.table.value.countryCode.XK??? 7
BB - Barbados 6
KG - Kirghizistan 6
PA - Panama 6
PR - Porto Rico 6
SK - Slovacchia (Repubblica Slovacca) 6
BS - Bahamas 5
BY - Bielorussia 5
CI - Costa d'Avorio 5
CY - Cipro 5
GR - Grecia 5
KH - Cambogia 5
MM - Myanmar 5
Totale 46.777
Salva come PNG Salva come JPEG
Città #
San Jose 3.428
Ashburn 3.084
Hong Kong 2.525
Singapore 2.162
Rome 1.556
Hefei 1.203
Council Bluffs 791
Boardman 707
Beijing 706
Columbus 621
London 559
Lauterbourg 525
Dallas 488
Shanghai 415
Santa Clara 386
Ho Chi Minh City 287
Los Angeles 204
New York 197
Phoenix 196
Hanoi 151
São Paulo 142
San Francisco 141
Munich 134
Seattle 94
Toronto 90
Pune 89
Mexico City 86
Chicago 73
Amsterdam 69
Washington 69
Milan 63
Denver 59
Brooklyn 56
Rio de Janeiro 56
Atlanta 53
Guayaquil 51
Montreal 51
Bogotá 50
Turku 50
Naples 49
Tokyo 49
Johannesburg 48
Las Vegas 47
Quito 46
Warsaw 46
Brasília 44
Frankfurt am Main 43
Buffalo 41
Orem 40
Philadelphia 40
Chennai 37
Da Nang 36
Brno 34
Melbourne 33
Helsinki 31
San José 30
St Louis 30
Boston 28
Tashkent 28
Manchester 26
Riyadh 26
Belo Horizonte 25
Medellín 24
Porto Alegre 24
The Dalles 24
Buenos Aires 23
Stockholm 23
Thái Bình 23
Haiphong 22
Istanbul 22
Jeddah 22
Kuala Lumpur 22
Baghdad 21
Charlotte 21
Houston 21
Palermo 21
Hangzhou 20
Jacksonville 20
Miami 20
Asunción 19
Bangkok 19
Biên Hòa 19
Bologna 19
Cleveland 19
The Bronx 19
Turin 19
Guangzhou 18
Kingston 18
New Delhi 18
Ribeirão Preto 18
Ankara 17
Curitiba 17
Jakarta 17
Manaus 17
Lima 16
Secaucus 16
Modena 15
Salvador 15
Bari 14
Boydton 14
Totale 23.260
Salva come PNG Salva come JPEG
Nome #
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 312
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 288
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 269
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 266
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 266
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 262
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 259
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 257
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 255
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 250
5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer 248
Early impairment of food intake in patients newly diagnosed with cancer 247
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 247
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study 247
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 244
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 244
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 242
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 242
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 241
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 241
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 240
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 237
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 236
Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation 235
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 233
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 232
[Methodological issues and first results of a record linkage between AIDS and Cancer Registries in Italy 232
Chondrosarcoma of the iliac wing in Von Hippel-Lindau disease 230
Prevention of radiotherapy-induced emesis 230
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 228
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 228
Premetastatic niche: ready for new therapeutic interventions? 227
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 226
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 225
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 221
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 218
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 215
Docetaxel induced pericardial effusion 214
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 213
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 212
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 211
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 209
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 205
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 201
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 187
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 181
A giant sarcoma of the parotid gland: A case report and review of the literature 178
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 176
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 173
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 170
A pathology-based combined model to identify pam50 non-luminal intrinsic disease in hormone receptor-positive HER2-negative breast cancer 169
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 165
A close relationship between HIF-1α expression and bone metastases in advanced NSCLC, a retrospective analysis 160
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 157
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 154
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 153
'Old' and 'new' drugs for the treatment of cancer pain 152
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 151
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 151
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 149
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 149
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 149
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 147
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 147
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 146
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 145
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 145
Colorectal carcinomas and PTEN/MMAC1 gene mutations 143
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 142
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 141
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 140
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 139
[Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors]. 139
Atypical chronic head and neck pain: don't forget Eagle's syndrome 138
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 137
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 137
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 137
[Neoplastic hypercalcemia]. 136
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 136
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 135
A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study 135
An omental mass: any hypothesis? 134
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 133
A form to report pain assessment and monitoring in the oncology clinical record: a Delphi process 132
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 132
Biological effects of cabozantinib on bone microenvironment 132
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 131
Azygo-tracheal fistula in a complete implantable central venous system 129
[Fluorouracil and high-dose folinic acid in the treatment of advanced colorectal carcinoma]. 128
Cerebellar metastasis from pancreatic adenocarcinoma. A case report 126
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 126
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 126
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 126
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 125
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 124
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 124
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 124
Brain microischemic phenomena in a woman receiving bevacizumab treatment: a case report 123
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial 123
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 122
Totale 18.494
Salva come PNG Salva come JPEG
Categoria #
all - tutte 327.227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 327.227
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022826 0 0 0 11 63 5 6 5 20 22 19 675
2022/2023202 22 7 3 19 9 8 18 18 12 1 76 9
2023/20242.026 46 228 137 146 186 872 21 131 26 67 78 88
2024/202519.040 311 224 781 138 150 472 324 79 1.660 1.529 6.204 7.168
2025/202618.923 1.669 739 1.263 2.160 674 1.141 4.822 1.601 1.537 1.708 844 765
2026/20276.018 401 2.126 2.519 972 0 0 0 0 0 0 0 0
Totale 47.048